CONCENTRATIONS |
3 Months Ended | |
---|---|---|
Mar. 31, 2019 | ||
Risks and Uncertainties [Abstract] | ||
CONCENTRATIONS | (9) CONCENTRATIONS For the three months ended March 31, 2019, the Company sourced approximately 57% of the components for its electrotherapy products from two significant vendors (defined as supplying at least 10%). For the three months ended March 31, 2018 the company sourced approximately 44% of components from one significant supplier. Management believes that its relationships with suppliers are good; however, if the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred. The Company had receivables from a private health insurance carrier at March 31, 2019 and December 31, 2018, that made up approximately 26% and 23%, respectively, of the net accounts receivable balance. |